This knowledge, coupled with our observations of increased T-cell activation within brain tumors, led us to hypothesize that CCR2+HSC-derived cells found within the brain tumor are differentiating into antigen-presenting cells, thereby activating lymphocytes within the brain tumor microenvironment. Here, CCR2 is linked to brain neoplasm.